Soulbrain (357780) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Feb, 2026Executive summary
Reviewed consolidated interim financial statements for the six months ended June 30, 2025, and 2024, with no material misstatements found under Korean IFRS 1034.
Major business includes manufacturing and sales of semiconductor and FPD chemical materials, and battery electrolytes, with expanded business through acquisition.
Financial highlights
Total assets increased to ₩1,341.6B as of June 30, 2025, from ₩1,168.2B at December 31, 2024.
Revenue for H1 2025 was ₩438.3B, up from ₩427.0B year-over-year.
Net income attributable to controlling interests for H1 2025 was ₩45.6B, compared to ₩90.2B in H1 2024.
Operating income for H1 2025 was ₩56.2B, up from ₩45.8B in H1 2024.
Cash and cash equivalents at period-end were ₩180.5B, down from ₩241.6B at the previous year-end.
Outlook and guidance
Business expansion expected from the acquisition of Sun Fluoro System Co., Ltd., broadening the product and market base.
No significant impact anticipated from recent accounting standard changes; ongoing review of future standard impacts.
Latest events from Soulbrain
- Revenue up 7% to ₩923.4B, but net income down 33% amid margin pressure and higher costs.357780
Q4 202522 Mar 2026 - Revenue and net income fell year-over-year, with major investments and lower cash reserves.357780
Q2 202420 Feb 2026 - Net income increased to ₩135.3B, with strong cash flow and higher EPS for the nine months.357780
Q3 202420 Feb 2026 - 2024 saw higher operating profit and cash, but net income fell on investment impairment.357780
Q4 202420 Feb 2026 - Q1 2025 revenue and profit declined year-over-year, with higher liabilities and major customer risk.357780
Q1 202520 Feb 2026 - Revenue and profit declined year-over-year, with increased investments and lower cash reserves.357780
Q3 202520 Feb 2026